{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:07:58Z","timestamp":1773338878921,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00066-009-2092-7","type":"journal-article","created":{"date-parts":[[2009,12,14]],"date-time":"2009-12-14T06:07:27Z","timestamp":1260770847000},"page":"775-781","source":"Crossref","is-referenced-by-count":39,"title":["Combined Cetuximab and Reirradiation for Locoregional Recurrent and Inoperable Squamous Cell Carcinoma of the Head and Neck","Cetuximab plus Rebestrahlung bei lokoregion\u00e4r rezidiviertem und inoperablem Plattenepithelkarzinom der Kopf-Hals-Region"],"prefix":"10.1007","volume":"185","author":[{"given":"Panagiotis","family":"Balermpas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Hambek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,15]]},"reference":[{"key":"2092_CR1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"J.A. Bonner","year":"2006","unstructured":"Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354: 567\u2013578.","journal-title":"N Engl J Med"},{"key":"2092_CR2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00066-007-1597-1","volume":"183","author":"D. Bottke","year":"2007","unstructured":"Bottke D, Bathe K, Wiegel T, et al. Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck. Strahlenther Onkol 2007;183:128\u2013132.","journal-title":"Strahlenther Onkol"},{"key":"2092_CR3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/annonc\/mdh308","volume":"15","author":"B. Brockstein","year":"2004","unstructured":"Brockstein B, Haraf DJ, Rademaker AW, et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 2004;15:1179\u20131186.","journal-title":"Ann Oncol"},{"key":"2092_CR4","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.1200\/JCO.2005.02.4646","volume":"23","author":"B. Burtness","year":"2005","unstructured":"Burtness B, Goldwasser MA, Flood W, et al. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic\/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol 2005;23:8646\u20138654.","journal-title":"J Clin Oncol"},{"key":"2092_CR5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"E.A. Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228\u2013247.","journal-title":"Eur J Cancer"},{"key":"2092_CR6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00066-009-1753-x","volume":"185","author":"E. Fokas","year":"2009","unstructured":"Fokas E, Wacker U, Gross MW, et al. Hypofractionated stereotactic reirradiation of recurrent glioblastomas. A beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol 2009;185:235\u2013240.","journal-title":"Strahlenther Onkol"},{"key":"2092_CR7","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2005.01.057","volume":"23","author":"M.K. Gibson","year":"2005","unstructured":"Gibson MK, Li Y, Murphy B, et al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an Intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2005;23:3562\u20133567.","journal-title":"J Clin Oncol"},{"key":"2092_CR8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00066-009-1969-9","volume":"185","author":"G. Henke","year":"2009","unstructured":"Henke G, Paulsen F, Steinbach JP, et al. Hypofractionated reirradiation for recurrent malignant glioma. Strahlenther Onkol 2009;185:113\u2013119.","journal-title":"Strahlenther Onkol"},{"key":"2092_CR9","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1200\/JCO.2005.07.120","volume":"23","author":"R.S. Herbst","year":"2005","unstructured":"Herbst RS, Arquette M, Shin DM, et al. Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck. J Clin Oncol 2005;23:5578\u20135587.","journal-title":"J Clin Oncol"},{"key":"2092_CR10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00066-008-1783-9","volume":"184","author":"B.A. Jereczek-Fossa","year":"2008","unstructured":"Jereczek-Fossa BA, Kowalczyk A, D\u2019Onofrio A, et al. Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients. Strahlenther Onkol 2008;184:36\u201340.","journal-title":"Strahlenther Onkol"},{"key":"2092_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00066-007-1632-2","volume":"183","author":"C. Kolotas","year":"2007","unstructured":"Kolotas C, Tselis N, Sommerlad M, et al. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy. Strahlenther Onkol 2007;183:69\u201375.","journal-title":"Strahlenther Onkol"},{"key":"2092_CR12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/CCO.0b013e3280f00ff8","volume":"19","author":"J.A. Langendijk","year":"2007","unstructured":"Langendijk JA, Bourhis J. Reirradiation in squamous cell head and neck cancer: recent developments and future directions. Curr Opin Oncol 2007;19:202\u2013209.","journal-title":"Curr Opin Oncol"},{"key":"2092_CR13","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1200\/JCO.2006.07.9194","volume":"25","author":"C.J. Langer","year":"2007","unstructured":"Langer CJ, Harris J, Horwitz EM, et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group protocol 9911. J Clin Oncol 2007;25:4800\u20134805.","journal-title":"J Clin Oncol"},{"key":"2092_CR14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/(SICI)1097-0347(199910)21:7<591::AID-HED1>3.0.CO;2-Y","volume":"21","author":"S.R. Mabanta","year":"1999","unstructured":"Mabanta SR, Mendenhall WM, Stringer SP, et al. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck 1999;21:591\u2013594.","journal-title":"Head Neck"},{"key":"2092_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00066-008-1731-8","volume":"184","author":"V. Milani","year":"2008","unstructured":"Milani V, Pazos M, Issels RD, et al. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer. Strahlenther Onkol 2008;184:163\u2013168.","journal-title":"Strahlenther Onkol"},{"key":"2092_CR16","unstructured":"Milanovic D, Adebahr S, Henke M. Wiederbestrahlung mit Cetuximab bei Patienten mit rezidivierten Kopf-Hals Tumoren. Strahlenther Onkol 2009;185: Sondernr 1:95."},{"key":"2092_CR17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"J.P. Pignon","year":"2009","unstructured":"Pignon JP, le Maitre A, Maillard E, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4\u201314.","journal-title":"Radiother Oncol"},{"key":"2092_CR18","first-page":"419","volume":"20","author":"J.A. Ridge","year":"1993","unstructured":"Ridge JA. Squamous cancer of the head and neck: surgical treatment of local and regional recurrence. Semin Oncol 1993;20:419\u2013429.","journal-title":"Semin Oncol"},{"key":"2092_CR19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/j.seminoncol.2008.03.010","volume":"35","author":"J.K. Salama","year":"2008","unstructured":"Salama JK, Vokes EE. Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer. Semin Oncol 2008;35: 251\u2013261.","journal-title":"Semin Oncol"},{"key":"2092_CR20","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0360-3016(01)01745-X","volume":"51","author":"S.A. Spencer","year":"2001","unstructured":"Spencer SA, Harris J, Wheeler RH, et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 2001;51: 1299\u20131304.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2092_CR21","first-page":"407","volume":"15","author":"P.M. Stell","year":"1989","unstructured":"Stell PM. Survival times in end-stage head and neck cancer. Eur J Surg Oncol 1989;15:407\u2013410.","journal-title":"Eur J Surg Oncol"},{"key":"2092_CR22","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","volume":"359","author":"J.B. Vermorken","year":"2008","unstructured":"Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008;359:1116\u20131127.","journal-title":"N Engl J Med"},{"key":"2092_CR23","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","volume":"357","author":"J.B. Vermorken","year":"2007","unstructured":"Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007;357:1695\u20131704.","journal-title":"N Engl J Med"},{"key":"2092_CR24","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1200\/JCO.2005.05.3850","volume":"24","author":"S.J. Wong","year":"2006","unstructured":"Wong SJ, Machtay M, Li Y. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? J Clin Oncol 2006;24:2653\u20132658.","journal-title":"J Clin Oncol"},{"key":"2092_CR25","unstructured":"Zwicker F, R\u00f6der F, M\u00fcnter M, et al. Kombinierte Radioimmuntherapie mit Cetuximab bei Re-Bestrahlungen von Karzinomrezidiven im Sch\u00e4del-\/Halsbereich. Strahlenther Onkol 2009;185:Sondernr 1:91."}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-2092-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-009-2092-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-2092-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:30:56Z","timestamp":1558578656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-009-2092-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["2092"],"URL":"https:\/\/doi.org\/10.1007\/s00066-009-2092-7","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}